You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

stage III gastric cancer

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC Trial in Beijing

Recruiting
  • NSCLC
    • Beijing, China
      Yuyan Wang
    Oct 10, 2023

    High-risk Stage II Colorectal Cancer, Stage III Colorectal Cancer, Circulating Tumor DNA Methylation Trial in Shanghai

    Recruiting
    • High-risk Stage II Colorectal Cancer
    • +2 more
    • mFOLFIRINOX adjuvant chemotherapy
    • mFOLFOX6/XELOX adjuvant chemotherapy
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Jul 12, 2023

    Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial

    Recruiting
    • Anatomic Stage I Breast Cancer AJCC v8
    • +2 more
    • Comprehensive Geriatric Assessment
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jun 23, 2023

    Stage I Adult Liver Cancer, Stage I Colorectal Cancer, Stage IA Gastric Cancer Trial in Duarte (Computer-Assisted Intervention,

    Completed
    • Stage I Adult Liver Cancer
    • +30 more
    • Computer-Assisted Intervention
    • +3 more
    • Duarte, California
      City of Hope Medical Center
    Jan 5, 2021

    High-risk Stage II Colorectal Cancer, Stage III Colorectal Cancer, Circulating Tumor DNA Methylation Trial in Shanghai (ctDNA

    Recruiting
    • High-risk Stage II Colorectal Cancer
    • +2 more
    • ctDNA methylation dynamic monitoring
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Jun 14, 2023

    Lung Cancer, Nonsmall Cell, Lung Cancer Stage III Trial (combination product, drug, procedure, radiation)

    Not yet recruiting
    • Lung Cancer, Nonsmall Cell
    • Lung Cancer Stage III
    • Nivolumab and Chemotherapy
    • +3 more
    • (no location specified)
    Aug 15, 2023

    Lung Cancer Stage III Trial (ctDNA)

    Not yet recruiting
    • Lung Cancer Stage III
    • ctDNA
    • (no location specified)
    Oct 26, 2023

    Radiotherapy Combined With EGFR-TKI for Stage III EGFR Mutant

    Completed
    • The Primary Study Metric is Progression-free Survival (PFS)
      • (no location specified)
      Jun 28, 2023

      Gastric Adenocarcinoma, Oligometastasis, Stage IV Esophageal Adenocarcinoma AJCC v7 Trial in Houston (drug, procedure,

      Recruiting
      • Gastric Adenocarcinoma
      • +4 more
      • Houston, Texas
        M D Anderson Cancer Center
      Sep 20, 2022

      Ovarian Cancer Trial in Birmingham (Carboplatin, olaparibp, embro)

      Not yet recruiting
      • Ovarian Cancer
      • Birmingham, Alabama
        O'Neal Comprehensive Cancer Center at UAB
      Jul 18, 2023

      Anatomic Stage I Breast Cancer, Anatomic Stage II Breast Cancer, Anatomic Stage III Breast Cancer Trial in United States

      Not yet recruiting
      • Anatomic Stage I Breast Cancer
      • +3 more
      • Endocrine Therapy
      • +7 more
      • Atlanta, Georgia
      • +4 more
      Jun 15, 2023

      Gastric Cancer Trial (Sintilimab)

      Not yet recruiting
      • Gastric Cancer
      • (no location specified)
      Oct 21, 2022

      Gastric Cancer, Adjuvant Chemo, XO Trial in Seoul (Docetaxel and capecitabine and oxaliplatin, capecitabine and oxaliplatin)

      Recruiting
      • Gastric Cancer, Adjuvant Chemotherapy, XO
      • Docetaxel and capecitabine and oxaliplatin
      • capecitabine and oxaliplatin
      • Seoul, Korea, Republic of
        Asan Medical Center
      Dec 30, 2022

      NSCLC Trial in Changsha (Sugemalimab and Chemotherapy)

      Recruiting
      • Carcinoma, Non-Small-Cell Lung
      • Sugemalimab and Chemotherapy
      • Changsha, China
        Hunan Cancer Hospital
      Jul 7, 2023

      Stage III NSCLC Trial (Toripalimab, JS004, Pemetrexed)

      Not yet recruiting
      • Stage III Non-small Cell Lung Cancer
      • (no location specified)
      Jun 3, 2023

      Stage III Fallopian Tube Cancer AJCC v7, Stage III Ovarian Cancer AJCC v6 and v7, Stage III Primary Peritoneal Cancer AJCC v7

      Active, not recruiting
      • Stage III Fallopian Tube Cancer AJCC v7
      • +14 more
      • Minneapolis, Minnesota
      • +1 more
      Jan 27, 2023

      Immunotherapy in Conversion Therapy of Unresectable Gastric

      Recruiting
      • Unresectable Gastric Cancer
        • Hangzhou, Zhejiang, China
          Zhejiang Cancer Hospital
        Nov 8, 2022

        Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial

        Recruiting
        • Anatomic Stage I Breast Cancer AJCC v8
        • +3 more
        • Duarte, California
          City of Hope Medical Center
        Sep 20, 2023

        Tislelizumab Combined With Chemotherapy in First-line Treatment

        Active, not recruiting
        • Tislelizumab
        • +3 more
        • Beijing, China
          Cancer Institute and Hospital, Chinese Academy of Medical Scienc
        Sep 6, 2023

        Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial

        Recruiting
        • Anatomic Stage I Breast Cancer AJCC v8
        • +3 more
        • Best Practice
        • +5 more
        • Ames, Iowa
          Mary Greeley Medical Center
        Jan 24, 2023

        Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial

        Recruiting
        • Anatomic Stage I Breast Cancer AJCC v8
        • +6 more
        • Biopsy
        • +3 more
        • Jacksonville, Florida
          Mayo Clinic in Florida
        Jan 6, 2023

        Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant

        Not yet recruiting
        • Breast Cancer Triple Negative
        • +3 more
          • Atlanta, Georgia
            Emory University/Winship Cancer Institute
          May 18, 2023

          Stomach Cancer Trial in Seoul (S-1 (452500ACH), OXALIPLATIN (205803BIJ))

          Terminated
          • Stomach Cancer
          • S-1 (452500ACH)
          • OXALIPLATIN (205803BIJ)
          • Seoul, Korea, Republic of
            Kangbuk Samsung Hospital
          Dec 6, 2022

          Colonic Tumors Trial (Dostarlimab, CAPEOX, FOLFOX)

          Not yet recruiting
          • Colonic Neoplasms
          • Dostarlimab
          • +2 more
          • (no location specified)
          May 3, 2023

          Melanoma Stage III Trial in Shanghai (Toripalimab combined with Temozolomide)

          Not yet recruiting
          • Melanoma Stage III
          • Toripalimab combined with Temozolomide
          • Shanghai, China
            Fudan University Shanghai Cancer Center
          Apr 23, 2023